Eastwood Bio-Medical Canada Inc (EBM : TSX-V)
Common Stock
Follow EBM
EBM
Eastwood Bio-Medical Canada Inc
WealthAwesomePerformance
1 Day
+2.22%
1 Week
-2.65%
1 Month
-5.15%
YTD
+93.68%
The Tuesday Stock Pick · free, every tuesday morning. One Canadian stock and the case for it.
Key Statistics
Market Cap
$123.99M
52W High
$2.06
52W Low
$0.49
P/E Ratio
-
50 Day MA
$1.87
200 Day MA
$1.13
Beta
0.32
Dividend Yield
-
WA Score
How EBM stacks up against 947 Canadian stocks
42
out of 99
- Value49
Not profitable over the last 12 months.
- Quality8
Return on equity −747.2%, profit margin −28.5%.
- Momentum75
93.7% this year, above its 200-day average, 86% of the way up its 52-week range.
- Analystsn/a
No analyst target on file.
- Insidersn/a
Not covered by our SEDI insider data yet.
Each factor is a percentile against Canadian common stocks worth $50M or more on the TSX and TSX Venture (90 = better than 90% of them). Built from exchange prices, company financials, analyst targets and SEDI insider filings. A data summary, not advice. How it works · Top-scoring stocks
Performance history
EBM returns since 2023
Eastwood Bio-Medical Canada Inc has traded since Nov 2023 in our data, with 1 up year out of 2 full calendar years. Its deepest fall was −72.7% (Nov 2023 to Jul 2024).
1 year / yr
+170.5%
3 years / yr
+18.6%
5 years / yr
—
10 years / yr
—
Calendar-year returns
- 2023*−50.0%
- 2024−1.8%
- 2025+50.0%
- 2026*+103.7%
* Partial year (first year of data, or year to date).
$10,000 invested in EBM
- 1 year ago$27,049
- 2023 (start of our data)$15,000
- Best year
- 2025: +50.0%
- Worst year
- 2024: −1.8%
- All-time high in our data
- $2 on Oct 2, 2026 · now −17.5%
Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), Nov 2023 to Nov 2026. Past returns do not predict future ones.
Awesome Portfolio™
Looking past EBM? Our 10 best Canadian stocks, in one list.
14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/10/2026 | $1.51 | $1.70 | $1.51 | $1.65 | $1.65 | 4,835 |
| 11/9/2026 | $1.70 | $1.88 | $1.70 | $1.84 | $1.84 | 1,470 |
| 11/6/2026 | $1.80 | $1.80 | $1.80 | $1.80 | $1.80 | 370 |
| 11/5/2026 | $1.90 | $1.90 | $1.90 | $1.90 | $1.90 | 100 |
| 11/4/2026 | $1.80 | $1.90 | $1.70 | $1.90 | $1.90 | 2,251 |
| 11/3/2026 | $1.76 | $1.99 | $1.76 | $1.93 | $1.93 | 7,034 |
| 11/2/2026 | $1.80 | $1.89 | $1.80 | $1.89 | $1.89 | 2,310 |
| 10/29/2026 | $1.90 | $1.90 | $1.90 | $1.90 | $1.90 | 350 |
| 10/28/2026 | $1.90 | $2.00 | $1.90 | $1.95 | $1.95 | 1,292 |
| 10/27/2026 | $1.99 | $1.99 | $1.98 | $1.99 | $1.99 | 3,069 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EBM's historical volatility
30-Day Vol
87.0%
Annualized
90-Day Vol
102.5%
Annualized
Trend (90d)
+26.3%
Annualized drift
90d Mean
C$1.81
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.70 | C$1.26 – C$2.30 |
| 60 trading days | C$1.76 | C$1.15 – C$2.69 |
| 90 trading days | C$1.81 | C$1.08 – C$3.05 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Eastwood Bio-Medical Canada Inc
Eastwood Bio-Medical Canada Inc. markets, develops research, and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin, which provides natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. It also offers Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for bones, teeth, and health; Eleotin G2000 for cardiovascular health; Eleotin H55 for sedative and tension relief; and Eleotin Zn330 for tissue formation and metabolism. In addition, the company provides Eleotin Bentley to promote healthy glucose levels; and Eleotin LBM for hypertension relief. It has a joint research agreement with BioNexus Inc. to build a platform that applies artificial intelligence to herbal ingredient prescription data in order to identify natural drug and functional food product candidates. The company was incorporated in 2010 and is based in Richmond, Canada. Eastwood Bio-Medical Canada Inc. operates as a subsidiary of Eastwood Bio-Medical Research Inc.
Financials
- Revenue (TTM)
- $812,116
- EBITDA
- $-147,529
- Profit Margin
- -28.51%
- ROE (TTM)
- -747.16%
- EPS (Diluted)
- -0.01
- Book Value
- -0.03
Classification
- Sector
- Consumer Staples
- Industry
- Consumer Staples Distribution & Retail
- Group
- Consumer Staples Distribution & Retail
Free newsletter
The Tuesday Stock Pick
One Canadian stock and the case for it
- The name with the biggest gap to analyst targets
- The chart, insider buying and what is driving it
- A plain-English bottom line, no hype
Explore More
Common Questions About EBM
Market movers
Recent TSX-V movers
Top 1-day gainers — updated from our Canadian movers feed.